How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation

BACKGROUND: In case of heparin-induced thrombocytopenia (HIT), the switch to a non-heparin anticoagulant is mandatory, at a therapeutic dose. Such a treatment has limitations though, especially for patients with renal and/or hepatic failure. Candidate laboratory tests could detect the more coagulabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Barocas, Antoine, Savard, Philippe, Carlo, Audrey, Lecompte, Thomas, de Maistre, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508023/
https://www.ncbi.nlm.nih.gov/pubmed/37726772
http://dx.doi.org/10.1186/s12959-023-00546-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508023/
https://www.ncbi.nlm.nih.gov/pubmed/37726772
http://dx.doi.org/10.1186/s12959-023-00546-8

Ejemplares similares